Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1462-1467

  Takeda, K ^a   Negoro, S ^a   Kudoh, S ^b   Okishio, K ^b   Masuda, N ^c   Takada, M ^c   Tanaka, M ^a   Nakajima, T ^b   Tada, T ^c   Fukuoka, M ^d  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Clinical trial; Irinotecan; Radiosensitization

Indexed keywords

IRINOTECAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG TOLERANCE; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL;

EID: 0033046643     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690233     Document Type: Article

References (30)

1. Andoh T, Ishii K, Suzuki Y, Ikegami Y, Kusunoki Y, Takemoto Y and Okada K (1987) Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase 1. Proc Natl Acad Sci USA 84: 5565-5569
2. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd and Green MR (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 940-945
3. Douple EB (1988) Platinum-radiation interactions. In NCI monographs, No. 6, pp 315-319. Government Printing Office: Washington, DC
4. Friess GG, Baikadi M and Harvey WH (1987) Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer. Cancer Treat Rep 71: 681-684
5. Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, Nakajima, S and Taguchi T (1992) A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol 10: 16-20
6. Holsti LR and Mattson K (1980) A randomized study of split-course radiotherapy of lung cancer: long term results. Int J Radiat Oncol Biol Phys 6: 977-981
7. Ihde DC and Minna JD (1991) Non-small cell lung cancer. Part II: Treatment. Curr Probl Cancer 15: 105-154
8. Jeremic B, Shibamoto Y, Acimovic L and Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14: 1065-1070
9. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
10. Kawato Y, Aonuma M, Hirota Y, Kuga H and Sato K (1991) Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187-4191
11. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY and Laplanche A (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83: 417-423
12. Masuda N, Fukuoka M, Fujita A, Kurita Y, Tsuchiya S, Nagao K, Negoro S, Nishikawa H, Katakami N, Nakagawa K and Niitani H (1998) A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group. Br J Cancer 78: 251-256
13. Mattson K, Holsti LR, Holsti P, Jakobsson M, Kajanti M, Lippo K, Mantyla M, Niitamo-Korhonen S, Nikkanen V, Nordman E, Platin LH, Pyrhonen S, Romppanen ML, Salmi R, Tammilehto L, and Taskinen PJ (1988) Inoperable non-small cell lung cancer: radiation with or without chemotherapy. European Journal of Cancer and Clinical Oncology 24: 477-482
14. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, Drummond RG, Laurie JA, Kugler JW and Anderson RT (1991) Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115: 681-686
15. Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225S-233S
16. Negoro S, Fukuoka M, Masuda N, Takada M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, Niitani H and Taguchi T (1991) Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer. J Natl Cancer Inst 83: 1164-1168
17. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655
18. Okishio K, Kudoh S, Kurihara N, Hirata K and Takeda T (1996) Irinotecan (CPT-11) enhances the radiosensitivity of lung cancer cells in vitro. Cellular Pharmacology 3: 247-252
19. Perez CA, Stanley K, Grundy G, Hanson W, Rubin P, Kramer S, Brady LW, Marks JE, Prez-Tamayo R, Brown GS, Concannon JP and Rotman M (1982) Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 50: 1091-1099
20. Pelo R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39
21. Petrovich Z, Stanley K, Cox JD and Paig C (1981) Radiotherapy in the management of locally advanced lung cancer of all cell types. Final report of randomized trial. Cancer 48: 1335-1340
22. Roswit B, Patno ME, Rapp R, Veinbergs A, Feder B, Stuhlbarg J and Reid CB (1968) The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 90: 688-697
23. Sause WT, Scott C, Taylor S, Byhardt RW, Banker FL, Thomson JW, Jones TK, Cooper JS and Lindberg RD (1992) Phase II trial of combination chemotherapy and irradiation in non-small cell lung cancer: Radiation Therapy Oncology Group 88-04. Am J Clin Oncol 15: 163-167
24. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR and Cox JD (1995) Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87: 198-205
25. Schaake-Koning C, van den Bogaert W, Dalesio O, Feslen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier JP, van Zandwijk N and Bartelink H (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524-530
26. Tamura K, Takada M, Kawase I, Tada T, Kudoh S, Okishio K, Fukuoka, M, Yamaoka N, Fujiwara Y and Yamakido M (1997) Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts. Jpn J Cancer Res 88: 218-223
27. Trovo MG, Minatel E, Veronesi A, Roncadin M, De Paoli A, Franchin G, Magri DM, Tirelli U, Carbone A and Grigoletto E (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. Cancer 65: 400-404
28. Trovo MG, Minatel E, Franchin G, Boccieri MG, Nascimben O, Bolzicco G, Pizzi G, Torretta A, Veronesi A, Gobitti C, Zanelli DJ and Monfardini S (1992) Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24: 11-15
29. Wingo PA, Tong T and Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45: 8-30
30. World Health Organization (1979) WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publications: Geneva